tirzepatide and eye issues dry & The Relationship Between Obesity & Skin What ODs Need to Know – Tirzepatide vs. Semaglutide: What You

PMID: Summary Keywords Crohns disease, GLP, GLP-1, GLP-2 receptor agonist, IBD - inflammatory bowel disease, ulcerative colitis Citation Lee JJ, Bajgain P and Lightner AL (2026) GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity

SURMOUNT-1 clinical trials studying the efficacy and safety of semaglutide 2.4 mg concluded that the patients lost 14.9% of their body weight after 68 weeks

Patients pay UCP directly

Special populations: additional blood work considerations Certain groups need modified monitoring approaches when using tirzepatide